News Detail
NEW DELHI, 23 NOV 2024: Abbott, the global healthcare company announced the launch of AVEIR™ VR single-chamber ventricular leadless pacemaker for the treatment of patients in India with slow heart rhythms. This pacemaker is now approved by Central Drugs Standard Contr......
View Details
Source : Abbott India
Cardiac electrophysiology
Embedded systems
Prosthetics
Neuroprosthetics
Medical devices
Artificial cardiac pacemaker
Cardiology
Abbott Laboratories
Clinical cardiac electrophysiology
Government Administration Activities
Hospitals
Clinics & Primary Care Services
Balbir Singh
Taiwan
Vanita Arora
Ajay Singh Chauhan
Chairman Cardiology
Max Superspeciality Hospital
electricity
chest incision
General Manager
India
US FOOD AND DRUG ADMINISTRATION
US Food and Drug Administration
Apollo Hospitals
Southeast Asia
Central Drugs Standard Control Organisation
Abbott
Related News
- Illegal cough syrup worth Rs 5 Crore seized at Assam-Tripura border (08-12-2024)
- Tragedy at Hyderabad Pharma: NGT Orders Accountability (08-12-2024)
- Experts Call for Urgent Standardisation and Quality Control of Herbal Medicines (08-12-2024)
- Experts Warn Against OTC Creams for Skin Issues: Potential Harm from Steroid Use (08-12-2024)
- Expert team will probe maternal deaths in Ballari hospital: Health Minister (08-12-2024)
- Maha FDA finds spurious drugs at rural GMCH in Beed, FIR against 4 suppliers (08-12-2024)
- CDSCO waives local clinical trials for new drugs approved in the USA, UK, Japan, Australia, Canada and EU: Govt in LS (07-12-2024)
- NDPS Act: SC explains law on presence of gazetted officer during search (07-12-2024)
- Contraband cough syrup seized from Tejas Rajdhani express (07-12-2024)
- Government has taken several measures to encourage domestic manufacturing: Govt in LS (07-12-2024)